All In Biotech

Drug Trial Radar · NCT00259350

Chlorhexidine vs Povidone Iodine in Alcoholic Solutions for Prevention of Central Venous Catheter Infection

Prevention of Central Venous Catheter Infections : Comparison of the Efficacy of Skin Disinfection With 5% Povidone Iodine in Alcoholic Solution Versus 0.25% Chlorhexidine, 0.025 Benzalkonium and 4% Benzylic Alcohol

Last checked: Nov 19, 2026Latest source record: Jan 27, 2009 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 520 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

520

Actual

Start

May 2004

Primary completion

Not stated

Study completion Apr 2006

Sponsor

Lead sponsor
Poitiers University HospitalAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Nov 29, 2005

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The best antiseptic solution for cateheter care remains unknown.High concentration in aquous solution or low concentration in alcoholic solution of chlorhexidine actbetter than povidone iodine in aquous solutions. No study has compare alcoholic formulations of low concentration of chlorhexidine and povidone iodine for skin disinfection prior to insertion of central venous catheters. To compare the incidence of central venous catheter colonization after skin disinfection with either an alcoholic solution of povidone iodine or a combination of 0.5% chlorhexidine, 0.025% Benzalkonium and 4% benzylic alcohol. To compare the incidence of catheter related bacteremia in the to study groups. To compare the local and general tolerance of the two antiseptic formulations

Conditions

  • ICU Patients Requiring a Central Venous Access

Interventions

  • Skin disinfectionDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Prevention of catheter colonization

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • University hospital

    Poitiers, Vienne, France

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.